Geron could resume stem cell trial
Geron Corp., a Menlo Park-based stem cell research company, has moved closer to a federal approval that would allow it to resume its testing of an embryonic stem cell therapy for spinal cord injuries. While the U.S. Food and Drug Administration …
[Read the full article here]Related News:
UCI stem-cell treatment is world’s first
Stem Cell Research Can Proceed, Says FDA
Geron says FDA lifts hold on stem cell trial